Skip to main content
Fig. 2 | Biology Direct

Fig. 2

From: Inhibition of RAC1 activator DOCK2 ameliorates cholestatic liver injury via regulating macrophage polarisation and hepatic stellate cell activation

Fig. 2

Silencing DOCK2 alleviates BDL-induced liver injury. (A) Schematic illustration of experimental protocols. (B) Representative microphotographs of IHC staining of DOCK2 in liver sections. Magnification: 200 fold. Scale bar: 100 μm. (C) Representative photographs of mouse livers. (D) Liver weight (LW)/body weight (BW) of mice. (E) Representative microphotographs of H&E staining of liver sections. Magnification: 40 fold. Scale bar: 500 μm. (F) Serum levels of total bilirubin (T-Bil), ALT (alanine aminotransferase), and AST (aspartate aminotransferase)

Back to article page

Biology Direct

ISSN: 1745-6150

Contact us